がん
CATEGORY
2007.1.1
A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5′ flanking region of SMYD3 is a risk factor for human cancers
2024.1.1
Genetic Architecture of Alcohol Consumption Identified by a Genotype-Stratified GWAS and Impact on Esophageal Cancer Risk in Japanese People
2023.1.31
Helicobacter pylori, Homologous-Recombination Genes, and Gastric Cancer
2023.1.31
Hereditary Cancer Variants and Homologous Recombination Deficiency in Biliary Tract Cancer
2023.1.30
Prediction Model with HLA-A*33:03 Reveals Number of Days to Develop Liver Cancer from Blood Test
2023.1.26
Genome-Wide Association Study of Lung Adenocarcinoma in East Asia and Comparison with a European Population
2023.1.27
Investigating the Association between Glycaemic Traits and Colorectal Cancer in the Japanese Population using Mendelian Randomisation
2023.1.21
Pan-Cancer and Cross-Population Genome-Wide Association Studies Dissect Shared Genetic Backgrounds Underlying Carcinogenesis
2023.1.19
GWAS of Folate Metabolism with Gene-Environment Interaction Analysis Revealed the Possible Role of Lifestyles in the Control of Blood Folate Metabolites in Japanese – the J-MICC Study
2023.1.15
Contribution of an Asian-prevalent HLA haplotype to the risk of HBV-related hepatocellular carcinoma
2023.1.14
ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
2023.1.13
Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects
2023.1.9
Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations
2023.1.7
Identification of Telomere Maintenance Gene Variations Related to Lung Adenocarcinoma Risk by Genome-Wide Association and Whole Genome Sequencing Analyses
2023.1.6
A large-scale microRNA transcriptome-wide association study identifies two susceptibility microRNAs, miR-1307-5p and miR-192-3p, for colorectal cancer risk
2023.1.4
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants
2022.1.27
Association between germline pathogenic variants in cancer-predisposing genes and lymphoma risk
2022.1.26
Population-based Screening for Hereditary Colorectal Cancer Variants in Japan
2022.1.20
Developing and validating polygenic risk scores for colorectal cancer risk prediction in East Asians
2022.1.18
Association of germline TYK2 variation with lung cancer and non-Hodgkin lymphoma risk
2022.1.17
Different risk genes contribute to clear cell and non-clear cell renal cell carcinoma in 1532 Japanese patients and 5996 controls
2022.1.15
Large-scale Integrated Analysis of Genetics and Metabolomic Data Reveals Potential Links Between Lipids and Colorectal Cancer Risk
2022.1.8
Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants
2022.1.7
Genome-wide risk prediction of common diseases across ancestries in one million people
2022.1.5
Genome-wide association study of colorectal polyps identified highly overlapping polygenic architecture with colorectal cancer
2022.1.4
Federated analysis of BRCA1 and BRCA2 variation in a Japanese cohort
2022.1.2
[Cohorts and Biobanks as Essential Resources for Cancer Research]
2022.1.1
A single-nucleotide-polymorphism in the 5′-flanking region of MSX1 gene as a predictive marker candidate for platinum-based therapy of esophageal carcinoma
2021.1.22
Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome-wide association study
2021.1.13
Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis
2021.1.10
Cancer-associated miRNAs and their therapeutic potential
2020.1.30
Germline pathogenic variants in 7,636 Japanese patients with prostate cancer and 12,366 controls
2020.1.24
Fine Mapping of the Major Histocompatibility Complex Region and Association of the HLA-B*52:01 Allele With Cervical Cancer in Japanese Women
2020.1.18
Genome-wide association meta-analysis identifies GP2 gene risk variants for pancreatic cancer
2020.1.15
Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes
2020.1.6
Prevalence and spectrum of pathogenic germline variants in Japanese patients with early-onset colorectal, breast, and prostate cancer
2019.1.21
12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population
2019.1.12
Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population
2019.1.9
Clinical and molecular characteristics of MEF2D fusion-positive B-cell precursor acute lymphoblastic leukemia in childhood, including a novel translocation resulting in MEF2D-HNRNPH1 gene fusion
2019.1.6
Novel Common Genetic Susceptibility Loci for Colorectal Cancer
2019.1.4
Genome-wide association study of cervical cancer suggests a role for ARRDC3 gene in human papillomavirus infection
2018.1.31
GWAS identifies two novel colorectal cancer loci at 16q24.1 and 20q13.12
2018.1.17
Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls
2018.1.9
Genome-wide association study identifies gastric cancer susceptibility loci at 12q24.11-12 and 20q11.21
2018.1.5
Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1
2017.1.26
Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations
2017.1.13
Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer
2017.1.12
Breast cancer chemoprevention pharmacogenomics: Deep sequencing and functional genomics of the ZNF423 and CTSO genes
2017.1.11
Calmodulin-like protein 3 is an estrogen receptor alpha coregulator for gene expression and drug response in a SNP, estrogen, and SERM-dependent fashion
2017.1.10
TCL1A Single-Nucleotide Polymorphisms and Estrogen-Mediated Toll-Like Receptor-MYD88-Dependent Nuclear Factor-κB Activation: Single-Nucleotide Polymorphism- and Selective Estrogen Receptor Modulator-Dependent Modification of Inflammation and Immune Response